-
1
-
-
0036770255
-
The nitric oxide pathway in the cardiovascular system
-
Llorens S, Jordan J, Nava E. The nitric oxide pathway in the cardiovascular system. J Physiol Biochem 2002; 58:179-188
-
(2002)
J Physiol Biochem
, vol.58
, pp. 179-188
-
-
Llorens, S.1
Jordan, J.2
Nava, E.3
-
2
-
-
0032526039
-
Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism
-
Giulivi C. Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism. Biochem J 1998; 332:673-679
-
(1998)
Biochem J
, vol.332
, pp. 673-679
-
-
Giulivi, C.1
-
3
-
-
0037064058
-
Biochemistry of mitochondrial nitric-oxide synthase
-
Elfering SL, Sarkela TM, Giulivi C. Biochemistry of mitochondrial nitric-oxide synthase. J Biol Chem 2002; 277: 38079-38086
-
(2002)
J Biol Chem
, vol.277
, pp. 38079-38086
-
-
Elfering, S.L.1
Sarkela, T.M.2
Giulivi, C.3
-
4
-
-
0033806490
-
The role of nitric oxide in metabolism regulation: From basic sciences to the clinical setting
-
Osorio JC, Recchia FA. The role of nitric oxide in metabolism regulation: from basic sciences to the clinical setting. Intensive Care Med 2000; 26:1395-1398
-
(2000)
Intensive Care Med
, vol.26
, pp. 1395-1398
-
-
Osorio, J.C.1
Recchia, F.A.2
-
5
-
-
0029161636
-
Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase
-
Brown GC. Nitric oxide regulates mitochondrial respiration and cell functions by inhibiting cytochrome oxidase. FEBS Lett 1995; 369:136-139
-
(1995)
FEBS Lett
, vol.369
, pp. 136-139
-
-
Brown, G.C.1
-
6
-
-
0038392976
-
Nitric oxide in inflammatory bowel disease
-
Cross RK, Wilson KT. Nitric oxide in inflammatory bowel disease. Inflamm Bowel Dis 2003; 9:179-189
-
(2003)
Inflamm Bowel Dis
, vol.9
, pp. 179-189
-
-
Cross, R.K.1
Wilson, K.T.2
-
8
-
-
0029401134
-
Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury
-
Harbrecht BG, Wu B, Watkins SC, et al. Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 1995; 4:332-337
-
(1995)
Shock
, vol.4
, pp. 332-337
-
-
Harbrecht, B.G.1
Wu, B.2
Watkins, S.C.3
-
9
-
-
0013292906
-
The role of nitric oxide in multiple sclerosis
-
Smith KJ, Lassmann H. The role of nitric oxide in multiple sclerosis. Lancet Neurol 2002; 1:232-241
-
(2002)
Lancet Neurol
, vol.1
, pp. 232-241
-
-
Smith, K.J.1
Lassmann, H.2
-
10
-
-
7944239290
-
Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease
-
Kharitonov SA, Barnes PJ. Nitric oxide, nitrotyrosine, and nitric oxide modulators in asthma and chronic obstructive pulmonary disease. Curr Allergy Asthma Rep 2003; 3:121-129
-
(2003)
Curr Allergy Asthma Rep
, vol.3
, pp. 121-129
-
-
Kharitonov, S.A.1
Barnes, P.J.2
-
11
-
-
0029886915
-
Significance of NO in hemorrhage-induced hemodynamic alterations, organ injury, and mortality in rats
-
Yao Y-M, Bahrami S, Leichtfried HR, et al. Significance of NO in hemorrhage-induced hemodynamic alterations, organ injury, and mortality in rats. Am J Physiol Heart Circ Physiol 1996; 270(5pt2): H1616-H1623
-
(1996)
Am J Physiol Heart Circ Physiol
, vol.270
, Issue.5 PART2
-
-
Yao, Y.-M.1
Bahrami, S.2
Leichtfried, H.R.3
-
12
-
-
0032790875
-
Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock
-
Szabo A, Hake P, Salzman AL, et al. Beneficial effects of mercaptoethylguanidine, an inhibitor of the inducible isoform of nitric oxide synthase and scavenger of peroxynitrite, in a porcine model of delayed hemorrhagic shock. Crit Care Med 1999; 27:1343-1350
-
(1999)
Crit Care Med
, vol.27
, pp. 1343-1350
-
-
Szabo, A.1
Hake, P.2
Salzman, A.L.3
-
13
-
-
0026334060
-
Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock
-
Lieberthal W, McGarry AE, Sheils J, et al. Nitric oxide inhibition in rats improves blood pressure and renal function during hypovolemic shock. Am J Physiol Renal Physiol 1991; 261:F868-F872
-
(1991)
Am J Physiol Renal Physiol
, vol.261
-
-
Lieberthal, W.1
McGarry, A.E.2
Sheils, J.3
-
14
-
-
0031306612
-
Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats
-
Harbrecht BG, Wu B, Watkins SC, et al. Inhibition of nitric oxide synthesis during severe shock but not after resuscitation increases hepatic injury and neutrophil accumulation in hemorrhaged rats. Shock 1997; 8:415-421
-
(1997)
Shock
, vol.8
, pp. 415-421
-
-
Harbrecht, B.G.1
Wu, B.2
Watkins, S.C.3
-
15
-
-
0029401134
-
Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury
-
Harbrecht BG, Wu B, Watkins SC, et al. Inhibition of nitric oxide synthase during hemorrhagic shock increases hepatic injury. Shock 1995; 4:332-337
-
(1995)
Shock
, vol.4
, pp. 332-337
-
-
Harbrecht, B.G.1
Wu, B.2
Watkins, S.C.3
-
16
-
-
0027055429
-
Protective actions of S-nitroso-N-acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock
-
Symington PA, Ma XL, Lefer AM. Protective actions of S-nitroso-N- acetylpenicillamine (SNAP) in a rat model of hemorrhagic shock. Methods Find Exp Clin Pharmacol 1992; 14:789-797
-
(1992)
Methods Find Exp Clin Pharmacol
, vol.14
, pp. 789-797
-
-
Symington, P.A.1
Ma, X.L.2
Lefer, A.M.3
-
17
-
-
0032014651
-
Inhibition of nitric oxide synthesis aggravates myocardial ischemia in hemorrhagic shock in constant pressure model
-
Adachi T, Hori S, Mijazaki K, et al. Inhibition of nitric oxide synthesis aggravates myocardial ischemia in hemorrhagic shock in constant pressure model. Shock 1998; 9:204-209
-
(1998)
Shock
, vol.9
, pp. 204-209
-
-
Adachi, T.1
Hori, S.2
Mijazaki, K.3
-
18
-
-
0032990946
-
An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock: Glaxo Wellcome International Septic Shock Study Group
-
Grover R, Zaccardelli D, Colice G, et al. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock: Glaxo Wellcome International Septic Shock Study Group. Crit Care Med 1999; 27:913-922
-
(1999)
Crit Care Med
, vol.27
, pp. 913-922
-
-
Grover, R.1
Zaccardelli, D.2
Colice, G.3
-
19
-
-
0036858431
-
Changes in nitric oxide and expression of nitric oxide synthase in spinal cord after acute traumatic injury in rats
-
Nakahara S, Yone K, Setoguchi T, et al. Changes in nitric oxide and expression of nitric oxide synthase in spinal cord after acute traumatic injury in rats. J Neurotrauma 2002; 19:1467-1474
-
(2002)
J Neurotrauma
, vol.19
, pp. 1467-1474
-
-
Nakahara, S.1
Yone, K.2
Setoguchi, T.3
-
20
-
-
0037561926
-
Exhaled biomarkers in COPD: Their potential role in diagnosis, treatment and prognosis
-
van Beurden WJ, Dekhuijzen PN, Smeenk FW. Exhaled biomarkers in COPD: their potential role in diagnosis, treatment and prognosis. Monaldi Arch Chest Dis 2002; 57:258-267
-
(2002)
Monaldi Arch Chest Dis
, vol.57
, pp. 258-267
-
-
Van Beurden, W.J.1
Dekhuijzen, P.N.2
Smeenk, F.W.3
-
22
-
-
0032872829
-
Increased carbon monoxide in exhaled air of patients with cystic fibrosis
-
Paredi P, Shah PL, Montuschi P, et al. Increased carbon monoxide in exhaled air of patients with cystic fibrosis. Thorax 1999; 54:917-920
-
(1999)
Thorax
, vol.54
, pp. 917-920
-
-
Paredi, P.1
Shah, P.L.2
Montuschi, P.3
-
23
-
-
0033837472
-
Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease
-
Paredi P, Kharitonov SA, Leak D, et al. Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am Rev Respir Crit Care Med 2000; 162:369-373
-
(2000)
Am Rev Respir Crit Care Med
, vol.162
, pp. 369-373
-
-
Paredi, P.1
Kharitonov, S.A.2
Leak, D.3
|